Ono Pharmaceutical Co., Ltd. (TYO:4528)
2,446.00
+13.50 (0.55%)
Nov 10, 2026, 3:30 PM JST
Ono Pharmaceutical Employees
Ono Pharmaceutical had 4,206 employees as of March 31, 2026. The number of employees decreased by 81 or 1.89% compared to the previous year. That makes Ono Pharmaceutical the 6,391st largest employer in the world and 615th in Japan.
Employees
4,206
Change (1Y)
-81
Growth (1Y)
-1.89%
Revenue / Employee
116.77M JPY
Profits / Employee
17.74M JPY
Market Cap
1.15T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 4,206 | -81 | -1.89% |
| Mar 31, 2025 | 4,287 | 434 | 11.26% |
| Mar 31, 2024 | 3,853 | 92 | 2.45% |
| Mar 31, 2023 | 3,761 | 74 | 2.01% |
| Mar 31, 2022 | 3,687 | 80 | 2.22% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Otsuka Holdings | 37,758 |
| HOYA Corporation | 37,752 |
| Tsuruha Holdings | 27,681 |
| M3, Inc. | 17,010 |
| MatsukiyoCocokara & Co. | 14,293 |
| Sysmex | 10,861 |
| Eisai | 10,543 |
Ono Pharmaceutical News
- 5 days ago - Ono Pharma Receives Orphan Medicinal Product Designation for Sapablursen from European Commission and Plans to Present Trial-in-Progress Poster at ASH 2026 - Business Wire
- 12 days ago - Ono Pharma Announces Results From Five Phase 2 Clinical Studies of ONO-1110, an Endocannabinoid Modulator - Business Wire
- 12 days ago - Ono Pharmaceutical Quarterly report: Q2 2027 - Filings
- 12 days ago - Ono Pharmaceutical Slides: Q2 2027 - Filings
- 18 days ago - Ono Pharmaceutical Co., - Depositary Receipt Price Target Increased by 12.00% to $5.41 - Nasdaq
- 2 months ago - Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases - Business Wire
- 3 months ago - Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases - Business Wire
- 3 months ago - Ono Pharmaceutical Quarterly report: Q1 2027 - Filings